ARCHIVES

DCT Board Approves More Than $25 Million In Contract Recompetitions, Two New Contracts

This article is from The Cancer Letter archive.

Vol. 16 No. 08 | February 23, 1990

Download PDF Visit The Full Archive

Related Articles

Rauscher Explains Reasons for Treatment Switches

May 9, 1975

In Brief: Breast Cancer Projects To Pay For Concurrent Pathology Review; Laetrile Study Entry Closed

May 19, 1978

Reviewers Report Progress In New Drug Prescreen System Development, Commend DTP

December 15, 1989

Revlimid Shows 91 Percent Response in Non-Hodgkin’s

July 29, 2011

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

June 5, 2009

New NIH Grant Program or Young Investigators

October 8, 2010